Acousort AB banner
A

Acousort AB
STO:ACOU

Watchlist Manager
Acousort AB
STO:ACOU
Watchlist
Price: 2.69 SEK -3.93% Market Closed
Market Cap: kr56.9m

Acousort AB
Investor Relations

AcouSort AB engages in the provision of biotechnology. The company is headquartered in Lund, Skane. The company went IPO on 2017-01-09. The firm develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Torsten Freltoft
Chief Executive Officer
No Bio Available
Dr. Stefan Scheding
Founder & Independent Director
No Bio Available
Dr. Hans Lilja
Founder
No Bio Available
Mr. Gunnar Telhammar
Chief Financial Officer
No Bio Available
Mr. Henrik Johansson
Director of Research & Technology
No Bio Available

Contacts

Address
SKANE
Lund
Medicon Village
Contacts